|
[1]
|
Gayen, S. (2022) Malignant Pleural Effusion: Presentation, Diagnosis, and Management. The American Journal of Medicine, 135, 1188-1192. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Madani, M.H., Riess, J.W., Brown, L.M., Cooke, D.T. and Guo, H.H. (2023) Imaging of Lung Cancer. Current Problems in Cancer, 47, Article 100966. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Salustros, N., Grønberg, C., Abeyrathna, N.S., Lyu, P., Orädd, F., Wang, K., et al. (2022) Structural Basis of Ion Uptake in Copper-Transporting P1b-Type Atpases. Nature Communications, 13, Article No. 5121. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Means, M.J., Santos, F.J.R., Sotardi, S.T. and Beslow, L.A. (2022) Menkes Disease: Clinical Presentation and Imaging Characteristics. Neuropediatrics, 53, 218-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Forcella, M., Lau, P., Oldani, M., Melchioretto, P., Bogni, A., Gribaldo, L., et al. (2020) Neuronal Specific and Non-Specific Responses to Cadmium Possibly Involved in Neurodegeneration: A Toxicogenomics Study in a Human Neuronal Cell Model. NeuroToxicology, 76, 162-173. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
da Silva, D.A., De Luca, A., Squitti, R., Rongioletti, M., Rossi, L., Machado, C.M.L., et al. (2022) Copper in Tumors and the Use of Copper-Based Compounds in Cancer Treatment. Journal of Inorganic Biochemistry, 226, Article 111634. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Blumenthal, R.D., Leon, E., Hansen, H.J. and Goldenberg, D.M. (2007) Expression Patterns of CEACAM5 and CEACAM6 in Primary and Metastatic Cancers. BMC Cancer, 7, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Baczyńska, D., Wietrzyk, J., Madej, J., Krop-Watorek, A., Dabrowska, A., Widerak, K., et al. (2003) The Tumorigenic Potential of Human CX-1 Colon Adenocarcinoma Cells Depends on Carcinoembryonic Antigen (CEACAM5) Expression. Cellular & Molecular Biology Letters, 8, 471-486.
|
|
[9]
|
Farzaneh, M., Nasrolahi, A., Ghaedrahmati, F., Masoodi, T., Najafi, S., Sheykhi-Sabzehpoush, M., et al. (2023) Potential Roles of LncRNA-Xist/miRNAs/mRNAs in Human Cancer Cells. Clinical and Translational Oncology, 25, 2015-2042. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Rajagopal, T., Talluri, S., Akshaya, R.L. and Dunna, N.R. (2020) HOTAIR LncRNA: A Novel Oncogenic Propellant in Human Cancer. Clinica Chimica Acta, 503, 1-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wei, D., Sun, D., Sirera, R., Afzal, M.Z., Leong, T.L., Li, X., et al. (2023) Overexpression of MRPL19 in Predicting Poor Prognosis and Promoting the Development of Lung Adenocarcinoma. Translational Lung Cancer Research, 12, 1517-1538. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Liu, L., Li, S., Qu, Y., Bai, H., Pan, X., Wang, J., et al. (2023) Ablation of ERO1A Induces Lethal Endoplasmic Reticulum Stress Responses and Immunogenic Cell Death to Activate Anti-Tumor Immunity. Cell Reports Medicine, 4, Article 101206. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lin, Y., Chen, Y., Zhang, Y., Weng, J., Shen, R., Lin, Y., et al. (2025) GATA6 Suppresses Lung Adenocarcinoma Progression by Activating CFTR to Modulate Arachidonic Acid Metabolism. Combinatorial Chemistry & High Throughput Screening, 28, 582-591. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhuang, X., Chen, P., Yang, K., Yang, R., Man, X., Wang, R., et al. (2024) MT1E in AML: A Gateway to Understanding Regulatory Cell Death and Immunotherapeutic Responses. Journal of Leukocyte Biology, 116, 1515-1529. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
刘其成. MT1E基因在肝癌中发挥抑癌作用的分子机制及其功能研究[D]: [博士学位论文]. 苏州: 苏州大学, 2021.
|
|
[16]
|
Ding, Y., Fang, J., Chen, M., Xu, Y., Liu, N., Fang, S., et al. (2022) MT1X Is an Oncogene and Indicates Prognosis in Ccrcc. Bioscience Reports, 42, BSR20221128. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Liu, Z., Ye, Q., Wu, L., Gao, F., Xie, H., Zhou, L., et al. (2018) Metallothionein 1 Family Profiling Identifies MT1X as a Tumor Suppressor Involved in the Progression and Metastastatic Capacity of Hepatocellular Carcinoma. Molecular Carcinogenesis, 57, 1435-1444. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Murphy, E. and Steenbergen, C. (2008) Mechanisms Underlying Acute Protection from Cardiac Ischemia-Reperfusion Injury. Physiological Reviews, 88, 581-609. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Bosman, M.C.J., Schuringa, J.J. and Vellenga, E. (2016) Constitutive NF-κB Activation in AML: Causes and Treatment Strategies. Critical Reviews in Oncology/Hematology, 98, 35-44. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Tan, Y., Lin, J., Li, T., Li, J., Xu, R. and Ju, H. (2020) LncRNA‐Mediated Posttranslational Modifications and Reprogramming of Energy Metabolism in Cancer. Cancer Communications, 41, 109-120. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Grammatikakis, I. and Lal, A. (2021) Significance of LncRNA Abundance to Function. Mammalian Genome, 33, 271-280. [Google Scholar] [CrossRef] [PubMed]
|